Allogene Therapeutics, Inc. (ALLO) vs Crescent Biopharma, Inc. (CBIO)
- Allogene Therapeutics, Inc. ALLO 1.31 −2.24%
- Crescent Biopharma, Inc. CBIO 11.84 −5.13%
Allogene Therapeutics, Inc. and Crescent Biopharma, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Crescent Biopharma, Inc. are of similar size ($463.6M and $463.0M). Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against −45.1%. Crescent Biopharma, Inc. has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 16 metrics below, Allogene Therapeutics, Inc. leads on 10 and Crescent Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | ALLO | CBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 19.72% | 65.16% |
| Operating margin | (3,832.45%) | 0.00% | 0.00% |
| Net margin | (3,517.41%) | 0.00% | 0.00% |
| Free cash flow margin | (2,180.62%) | 0.00% | 0.00% |
| Return on equity | (42.39%) | (112.14%) | (56.36%) |
| Return on assets | (32.43%) | (97.08%) | (48.04%) |
| Return on invested capital | (108.81%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack